Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

X-linked severe combined immunodeficiency.

M E Conley1

  • 1Department of Pediatrics, University of Tennessee College of Medicine, Memphis.

Clinical Immunology and Immunopathology
|November 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.

The New England journal of medicine·2016
Same author

Frequent mutations in SH2D1A (XLP) in males presenting with high-grade mature B-cell neoplasms.

Pediatric blood & cancer·2013
Same author

Membranous glomerulopathy in an adult patient with X-linked agammaglobulinemia receiving intravenous gammaglobulin.

Journal of investigational allergology & clinical immunology·2011
Same author

A minimally hypomorphic mutation in Btk resulting in reduced B cell numbers but no clinical disease.

Clinical and experimental immunology·2008
Same author

A possible bichromatid mutation in a male gamete giving rise to a female mosaic for two different mutations in the X-linked gene WAS.

Clinical genetics·2007
Same author

A newly recognized, likely autosomal recessive syndrome comprising agammaglobulinemia, microcephaly, craniosynostosis, severe dermatitis, and other features.

American journal of medical genetics. Part A·2006
Same journal

Mechanisms of virus replication, persistence, and regulation of immune responses.

Clinical immunology and immunopathology·2020
Same journal

Cumulative subject index for volumes 86-89

Clinical immunology and immunopathology·1998
Same journal

D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.

Clinical immunology and immunopathology·1998
Same journal

Characterization of gastric Na+/I- symporter of the rat.

Clinical immunology and immunopathology·1998
Same journal

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

Clinical immunology and immunopathology·1998
Same journal

Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Clinical immunology and immunopathology·1998
See all related articles

New mutations cause X-linked severe combined immunodeficiency (SCID) in many boys. Bone marrow transplants improve T-cell engraftment but B-cell engraftment and function remain challenging, necessitating improved transplant strategies.

Area of Science:

  • Immunology
  • Genetics
  • Pediatrics

Background:

  • X-linked severe combined immunodeficiency (SCID) affects T-cell development.
  • A significant proportion of SCID cases arise from new gene mutations.
  • Patients exhibit reduced T-cells, elevated B-cells, and hypogammaglobulinemia.

Purpose of the Study:

  • To investigate the genetic basis and clinical manifestations of X-linked SCID.
  • To evaluate the efficacy of bone marrow transplantation in SCID patients.
  • To identify challenges in B-cell engraftment and function post-transplant.

Main Methods:

  • Analysis of genetic mutations in SCID patients without a family history.
  • Comparison of clinical and immunological profiles between SCID patient groups.

Related Experiment Videos

  • Assessment of T-cell and B-cell engraftment and function after bone marrow transplant.

    • Main Results:

    • New gene mutations are a primary cause of X-linked SCID in approximately 33-50% of affected males.
    • Patients present with similar immunological defects regardless of family history.
    • T-cell engraftment is successful post-transplant, but B-cell engraftment and function are often impaired.

    Conclusions:

    • The genetic defect in X-linked SCID impacts both T-cells and B-cells.
    • Current bone marrow transplant protocols require optimization for B-cell engraftment and function.
    • Improved transplant strategies are crucial for achieving better long-term outcomes in X-linked SCID patients.